LifeScience Emerging Biotech
Intellectual Property Portfolio Includes 39 Granted and Pending Patents in the U.S. and Internationally, Providing Protection Into 2041, Unless Extended Fu...
February 17, 2026 | News
- Lilac Biosciences, a biotechnology company spun out of the Giuliani RNA Center at Brown University, developing quantitative RNA-based analytical too...
February 17, 2026 | News
First SIRPα-IgG4 Fc Fusion Protein Granted Orphan Status in Gastric Cancer HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnolog...
February 16, 2026 | News
AsymBio, a subsidiary of Asymchem Group (stock code: 002821.SZ / 6821.HK), announced that it has established integrated technology platforms span...
February 12, 2026 | News
Zhejiang Difference Biological Technology Co., Ltd. (DIFF Biotech) announced that its proprietary nasal spray influenza attenuated live vaccine, DIFF-flu, ...
February 10, 2026 | News
Delonix Bioworks, a clinical-stage biotechnology company developing next-generation bacterial vaccines, recently announced that its Group B...
February 09, 2026 | News
Samsung Biologics' PCF system validated in line with globally established ISO and PAS standards Validation reflects continued efforts to establish ...
February 09, 2026 | News
- Korean courts order Intercos Korea to bear full legal costs, affirming both civil and criminal liability Kolmar Korea has secured a decisive legal ...
February 09, 2026 | News
SanegeneBio grants exclusive worldwide license to one of its RNAi programs to Genentech - SanegeneBio to receive $200 million up...
February 04, 2026 | News
Monash Innovation Labs and Agilent Technologies Australia have formalised a new partnership to embed advanced analytical instrumentation wit...
February 03, 2026 | News
Frontage Laboratories, Inc. ("Frontage"), a global Contract Research, Development and Manufacturing Organization (CRDMO), announced the expansion of ...
February 03, 2026 | News
Azenta Life Sciences offers a range of low binding consumables that deliver consistent performance from sensitive applications tha...
February 02, 2026 | News
Novel TL1A/IL23p19 bispecific antibody targets drivers of disease pathogenesis to overcome the efficacy ceiling in inflammatory bowel disease. Lice...
January 29, 2026 | News
Kazia Therapeutics provided a clinical update from its ongoing Phase 1b study evaluating paxalisib in combination with pembrolizumab and chemothe...
January 29, 2026 | News
Most Read
Bio Jobs
News